Associate Director, Medical Information
Orca BioFull Time
Expert & Leadership (9+ years)
Candidates must possess a Bachelor's degree in pharmacy or a scientific discipline, coupled with a minimum of 3 years of experience in medical information and medical review within the pharmaceutical industry. Required skills include in-depth knowledge of pharmaceutical industry codes and legislation relevant to medical information, expertise in drug information communication and management, and extensive knowledge of information retrieval, dissemination processes, medical information systems, and databases. Proficiency in Microsoft Office, excellent verbal and written communication skills, the ability to work independently and collaboratively in a fast-paced, matrixed team environment, strong analytical and problem-solving skills, and excellent planning, organization, and time management skills are also essential. An advanced degree (PharmD, PhD, Masters) is preferred.
The Contractor, Medical Information and Review Specialist will provide second-line expertise for inquiries escalated from the medical information call center, conduct literature searches, and write custom responses. They will contribute to inquiry metric reports, generate standard response and FAQ documents, and suggest process improvements. Responsibilities also include reviewing commercial and medical materials for scientific and medical accuracy, ensuring adherence to regulatory requirements and SOPs, and interpreting medical literature for compliant communication. The role involves identifying potential business risks, attending medical congresses to answer questions, staying updated on industry developments, providing medical/scientific alerts, participating in meetings to promote medical information services, and contributing to allocated medical services projects.
Develops therapies for CNS disorders
Axsome Therapeutics develops therapies for central nervous system (CNS) disorders, focusing on conditions like major depressive disorder, treatment-resistant depression, and Alzheimer's agitation. Their main product, AXS-05, is an oral medication that works by blocking NMDA receptors in the brain, which helps regulate mood. This drug has shown positive results in clinical trials and has received special FDA status to speed up its approval process. Unlike many competitors, Axsome emphasizes addressing unmet medical needs in CNS disorders and aims to improve patient outcomes through rigorous research and development. The company's goal is to bring effective treatments to market, enhancing the quality of life for patients suffering from these conditions.